Clinical Trial

Augmenting Urinary Reflex Activity: Study 3

Study acronym: AURA-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-09-13; most recent amendment 2025-05-14.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-05-14
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-01-09
Trial Details
NCT Number NCT06597994
Lead Sponsor Amber Therapeutics Ltd
Conditions Urinary Incontinence
Enrollment 12 participants
Start Date 2025-01-15
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-15